Basic Information
Congruence Therapeutics is a drug discovery company leveraging the power of innovative fields such as protein dynamics, biophysics, machine learning, and computational chemistry. Congruence Therapeutics has developed a purpose-built computational drug discovery engine called Revenir™, which captures biophysical changes caused by protein mutations. By examining surface characteristics and numerous biophysical descriptors of both mutant and wild-type proteins, Congruence Therapeutics establishes an understanding of the defect and how to correct it in real time.
Congruence Therapeutics, Inc.
Montreal,Quebec,Canada
15~50 people
January 01, 2021
--

